Hennepin Healthcare Research Institute, Minneapolis, Minnesota.
College of Design, University of Minnesota, Minneapolis, Minnesota.
Clin Transplant. 2018 Dec;32(12):e13426. doi: 10.1111/ctr.13426. Epub 2018 Oct 31.
The Scientific Registry of Transplant Recipients (SRTR) provides federally mandated program-specific transplant data to the public. Currently, there is little understanding of how different program measures are prioritized by patients in selecting a program for transplantation. This study recruited 479 transplant advocacy group members from mailing lists and social media of the National Kidney Foundation (NKF), transplant families (TF), and Transplant Recipient International Organization (TRIO). Survey participants identified how many different programs would be reasonable to consider and viewed four measures that have recently been displayed on SRTR public search result websites and six measures not recently displayed and indicated importance on a 5-point scale. Four hundred two completed the survey (TF = 26; TRIO = 34; NKF = 342). Seventy-eight percent indicated that considering more than one program would be reasonable. Linear mixed models adjusted for organization, education, and gender. Likert scores for pretransplant (transplant rate) and transplant volume measures were similar and were very or extremely important to over 80% of participants. Posttransplant (survival after transplant) was rated as 0.52 points higher, confidence interval (0.41, 0.64). Results indicate that many patient advocacy group members find a choice between two or more programs reasonable and value multiple measures when assessing programs where they may want to undergo transplantation.
器官移植受者科学登记处(SRTR)向公众提供联邦授权的特定于项目的移植数据。目前,对于患者在选择移植项目时如何优先考虑不同项目措施,了解甚少。本研究从全国肾脏基金会(NKF)、移植家庭(TF)和移植受者国际组织(TRIO)的邮寄名单和社交媒体招募了 479 名移植倡导小组成员。调查参与者确定了考虑多少个不同的项目是合理的,并查看了最近在 SRTR 公共搜索结果网站上显示的四项措施和六项最近未显示的措施,并在 5 分制上表示重要性。402 人完成了调查(TF=26;TRIO=34;NKF=342)。78%的人表示考虑一个以上的项目是合理的。线性混合模型根据组织、教育和性别进行了调整。移植前(移植率)和移植量措施的李克特评分相似,超过 80%的参与者认为非常或极其重要。移植后(移植后的生存)的评分高 0.52 分,置信区间(0.41,0.64)。结果表明,许多患者倡导小组成员认为在两个或多个项目之间进行选择是合理的,并在评估他们可能希望进行移植的项目时,重视多个措施。